<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Poltavskaya EG</submitter><funding>Russian Science Foundation</funding><pagination>997</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8540378</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(10)</volume><pubmed_abstract>Schizophrenia is a complex mental disorder with a high heritability. Dysfunction of the N-methyl-D-aspartate (NMDA)-type glutamate receptors may be involved in the pathogenesis of schizophrenia. In this study, we examined the contribution of GRIN2A and GRIN2B (Glutamate Ionotropic Receptor NMDA Type Subunit 2A/2B) polymorphisms to the clinical features of schizophrenia, such as the leading symptoms, the type of course, and the age of onset. A population of 402 Russian patients with schizophrenia from the Siberian region was investigated. Genotyping of seventeen single-nucleotide polymorphisms (SNPs) in GRIN2A and GRIN2B was performed using QuantStudio™ 3D Digital PCR System Life Technologies amplifier using TaqMan Validated SNP Genotyping Assay kits (Applied Biosystems). The results were a</pubmed_abstract><journal>Life (Basel, Switzerland)</journal><pubmed_title>Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms.</pubmed_title><pmcid>PMC8540378</pmcid><funding_grant_id>21-15-00212</funding_grant_id><pubmed_authors>Poltavskaya EG</pubmed_authors><pubmed_authors>Fedorenko OY</pubmed_authors><pubmed_authors>Kornetova EG</pubmed_authors><pubmed_authors>Kornetov AN</pubmed_authors><pubmed_authors>Loonen AJM</pubmed_authors><pubmed_authors>Bokhan NA</pubmed_authors><pubmed_authors>Ivanova SA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms.</name><description>Schizophrenia is a complex mental disorder with a high heritability. Dysfunction of the N-methyl-D-aspartate (NMDA)-type glutamate receptors may be involved in the pathogenesis of schizophrenia. In this study, we examined the contribution of GRIN2A and GRIN2B (Glutamate Ionotropic Receptor NMDA Type Subunit 2A/2B) polymorphisms to the clinical features of schizophrenia, such as the leading symptoms, the type of course, and the age of onset. A population of 402 Russian patients with schizophrenia from the Siberian region was investigated. Genotyping of seventeen single-nucleotide polymorphisms (SNPs) in GRIN2A and GRIN2B was performed using QuantStudio™ 3D Digital PCR System Life Technologies amplifier using TaqMan Validated SNP Genotyping Assay kits (Applied Biosystems). The results were a</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-05T12:57:18.73Z</modification><creation>2025-04-05T12:57:18.73Z</creation></dates><accession>S-EPMC8540378</accession><cross_references><pubmed>34685369</pubmed><doi>10.3390/life11100997</doi></cross_references></HashMap>